← Open Payments lookup

CAROLINE SCHULENBERG: Open Payments

NPI 1770140824 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,725 in 33 payments from 14 companies in 2025. Trend: 2023 $1,075 · 2024 $879 · 2025 $1,725

Food & beverage: $1,725
CompanyPaymentsAmount
Gilead Sciences, Inc.7$516
Ipsen Biopharmaceuticals, Inc2$252
ABBVIE INC.8$197
Mallinckrodt Hospital Products Inc.1$149
Janssen Scientific Affairs, LLC1$139
GENZYME CORPORATION1$125
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$101
Janssen Biotech, Inc.3$77
Takeda Pharmaceuticals U.S.A., Inc.3$52
Madrigal Pharmaceuticals1$28

Products named: TERLIVAZ, Bylvay, Livdelzi, IQIRVO, Vemlidy, DUPIXENT, XIFAXAN, LINZESS.

Industry payments across LA — which companies pay providers there.